Ex-major-leaguer indicted in med device insider trading scheme; Mindray's recall gets Class I label;

 @FierceMedDev: eBay co-founder invests heavily in India's medtech industry. Item | Follow @FierceMedDev

@MarkHFierce: Indictments filed in a long-standing med device insider trading case. An ex Angels ball player is involved. More | Follow @MarkHFierce

 @DamianFierce: With St. Jude's $1B stock repurchase, the company says the future will be stable. Do investors agree? Story | Follow @DamianFierce

> A former major league baseball player and three other people have been indicted for allegedly using insider-trading information to buy stock in Advanced Medical Optics, which Abbott Labs ($ABT) subsequently snatched up for $3 billion in 2009. Story

> Mindray Medical's ($MR) voluntary recall of anesthesia devices got slapped with a Class I label--the most serious--by the FDA. More

> NeuroMetrix ($NURO) won 510(k) clearance for a disposable electrode used with its Sensus pain management device--which allows the company to begin marketing the product in the U.S. Release

> Transcranial magnetic stimulation helped people with spinal cord injuries improve the use of their hands, according to a new study. Story

> Varian Medical Systems ($VAR) gained regulatory clearance from India's Atomic Energy Regulatory board to use the high-intensity mode of its TrueBeam medical linear accelerator for advanced radiosurgical treatments. Item

> Abiomed's ($ABMD) shareholder woes continue as it faces another class-action lawsuit, claiming it made false statements related to the safety of its Impella 2.5 device. News

> Tangent Medical Technologies, maker of a closed-system IV device, has raised $8.6 million to bring the tech to market. Report

> Devicemaker Verathon, which is owned by Roper ($ROP), is launching a voluntary recall of reusable blades in its GlideScope GVL video laryngoscope. Article

Biotech News

 @FierceBiotech: From FierceBiotechIT.com: Study: Genomics, outsourcing fuel double-digit growth in bioinformatics. Report | Follow @FierceBiotech

 @JohnCFierce: BioCryst ends a very bad, disastrous, no good of any kind of month by terminating merger pact. News | Follow @JohnCFierce

 @RyanMFierce: Sounds like adult blood could best skin cells as source for stem cells. We'll see. BBC report. More | Follow @RyanMFierce

> Big Pharma backers fuel $17M first round for developer of brain-penetrating protein drugs. Article

> Exelixis grabs first FDA nod for blockbuster hopeful against thyroid cancer. Story

Pharma News

@FiercePharma: Ranbaxy stops making generic Lipitor as news of 2nd recall surfaces. Story | Follow @FiercePharma

> Presidio, BioCryst call off $101 million merger. Item

> Theravance wins partial victory for Vibativ. News

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.